Terrence Cochrane

Terrence (Terry) Cochrane is President of BrevisRefero Corporation in Ontario, Canada. Mr. Cochrane brings decades of life sciences industry experience to Oragenics, with over 20 years of progressive management experience in biopharmaceutical development and the GMP manufacturing industry for biologic therapies and vaccines. BrevisRefero provides biopharma outsourcing assistance in identifying and selecting service providers and follow-on technical program management to facilitate the delivery of products to clinic and market. Mr. Cochrane holds a B.S. from the University of Winnipeg in Biochemistry and Biology.